Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Omega-3-carboxylic Acids Prototypes vs Epanova
NCT02359045Phase 1Completed
- Sponsor
- AstraZeneca
- Start
- Feb 2015
- Primary completion
- Jul 2015
- Modality
- Liposomes, Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of omega-3-carboxylic acids in hypertriglyceridemia (2 arms), sponsored by AstraZeneca. Primary endpoints: Area Under the Plasma Concentration-time Curve From Zero to Infinity, Area Under the Plasma Concentration-time Curve From Time Zero to 72 Hours and 1 more. Started Feb 2015; status: completed.
02
Drugs
omega-3-carboxylic acids
03
Conditions
hypertriglyceridemia
Beyond the preview
Go deeper on NCT02359045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02359045.